Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kingfa Science & Technology (India) Ltd Capital/Financing Update 2026

Feb 9, 2026

61430_rns_2026-02-09_44c40dd6-b53d-4547-a7b0-e8b2d771e391.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Date: 09/02/2026

==> picture [82 x 19] intentionally omitted <==

KINGFA/SE/2025-26

To,

National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G- Block, Bandra –Kurla Complex, Bandra (East), Mumbai 400051

Symbol: KINGFA

BSE Limited

Corporate Relationship Department 1[st] Floor, New Trading Ring, Rotunda Building, P.J. Towers, Dalal Street, Fort, Mumbai 400001

Scrip Code: 524019

Subject: Monitoring Agency Report for the quarter ended December 31, 2025.

Dear Sir/Madam,

Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed herewith the Monitoring Agency Report with respect to the utilization of issue proceeds for the quarter ended December 31, 2025 issued by CARE Ratings Limited.

Kindly be informed that the enclosed monitoring agency report was placed before the Audit Committee for review and before the Board of Directors of the Company.

We request you to take the above information on record.

Thanking You,

Yours faithfully

For Kingfa Science & Technology (India) Limited

DEEPA Digitally signed by DEEPAK VYAS Date: 2026.02.09 K VYAS 11:49:33 +05'30' _____ Deepak Vyas Company Secretary & Compliance officer

==> picture [89 x 88] intentionally omitted <==

Kingfa Science & Technology (India) Limited

CIN: L25209TN1983PLC010438 Regd. Office: Dhun Building, III Floor, 827, Anna Salai, Chennai - 600002. Tel: +44 – 28521736 Fax: +44 – 28520420 E-mail: [email protected]

Website: www.kingfaindia.com

==> picture [596 x 133] intentionally omitted <==

==> picture [4 x 15] intentionally omitted <==

No. CARE/ARO/GEN/2025-2026/1318

The Board of Directors Kingfa Science & Technology (India) Limited

Dhun Building, 3[rd] Floor, 827, Mount Road, Madras, Tamilnadu, India – 600002

February 09, 2026

Dear Sir,

- Monitoring Agency Report for the quarter ended December 31, 2025 in relation to the preferential issue of Kingfa Science & Technology India Limited (“the Company”)

We write in our capacity of Monitoring Agency for the preferential issue for the amount aggregating to Rs.500 crore of the Company and refer to our duties cast under Regulation 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.

In this connection, we are enclosing the Monitoring Agency Report for the quarter ended December 31, 2025, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated September 08, 2025.

Request you to kindly take the same on records.

Thanking you, Yours faithfully,

==> picture [122 x 21] intentionally omitted <==

Jignesh Trivedi Assistant Director [email protected]

1

Report of the Monitoring Agency

Name of the issuer: Kingfa Science & Technology (India) Limited For quarter ended: December 31, 2025 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil

(b) Range of Deviation: Not applicable

Declaration:

We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013.

The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.

We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.

==> picture [122 x 21] intentionally omitted <==

Signature:

Name and designation of the Authorized Signatory: Jignesh Trivedi Designation of Authorized person/Signing Authority: Assistant Director

2

1) Issuer Details:

Name of the issuer : Kingfa Science & Technology (India) Limited Name of the promoter : Kingfa Science & Technology Co. Ltd (KSTCL; Parent Company) Industry/sector to which it belongs : Industrials – Capital Goods – Industrial Products – Plastic Products Industrial

2) Issue Details

Issue Period : Not applicable Type of issue (public/rights) : Preferential Issue Type of specified securities : Equity Shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs.500 crore

3) Details of the arrangement made to ensure the monitoring of issue proceeds:

Particulars Reply Source of information /
certifications considered by
Monitoring Agency for
preparation of report
Comments of the
Monitoring Agency
Comments of the
Board of Directors
Whether all utilization is as per the
disclosures in the Offer Document?
Yes CA Certificate*
Management Certificate
Bank Statement
Sample Invoices
KSTIL
utilized
Rs.60.29
crore
towards procurement of plant and
machinery and Rs.54.86 crore
towards GCP during Q3FY26.
Nil
Whether shareholder approval has been
obtained in case of material deviations#
from expenditures disclosed in the Offer
Document?
Not applicable CA Certificate*
Management Certificate
Bank Statement
Nil Nil
Whether the means of finance for the
disclosed objects of the issue have changed?
No Management Certificate Nil Nil
Is there any major deviation observed over
the earlier monitoring agency reports?
Not applicable Management Certificate
Monitoring Agency Report (dated
November 12,2025)
No Nil
Whether all Government/statutory
approvals related to the object(s) have been
obtained?
Government/statutory
approvals (if required) related
to any object will be obtained
as and when required
Management Certificate Nil Nil
Whether all arrangementspertainingto Not applicable Management Certificate Nil Nil

==> picture [37 x 21] intentionally omitted <==

3

Particulars Reply Source of information /
certifications considered by
Monitoring Agency for
preparation of report
Comments of the
Monitoring Agency
Comments of the
Board of Directors
technical assistance/collaboration are in
operation?
Are there any favorable/unfavorable events
affectingthe viabilityof these object(s)?
No Management Certificate Nil Nil
Is there any other relevant information that
may materially affect the decision making of
the investors?
No Management Certificate Nil Nil

* Chartered Accountant certificate from M/s. P G Bhagwat LLP dated January 24, 2026

#Where material deviation may be defined to mean:

a) Deviation in the objects or purposes for which the funds have been raised

b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents.

Details of objects to be monitored:

(i) Cost of objects –

Sr.
No
Item
Head
Source of information /
certifications considered
by Monitoring Agency for
preparation of report
Original cost
(as per the Offer
Document) in Rs.
Crore
Revised Cost
in Rs. Crore
Comments
of the
Monitoring
Agency
Comments of the Board of Directors Comments of the Board of Directors Comments of the Board of Directors
Reason for
cost revision
Proposed
financing option
Particulars of
-firm
arrangements
made
1 Phase 2 Factory/Phase II
Building Construction-at
Chakan,Pune
EGM Notice, Management
certificate, CA Certificate*
187.00 NA Nil Nil Nil Nil
2 Office Administration, R&D
Building– at Chakan Pune
EGM Notice, Management
certificate,CA Certificate*
44.00 NA Nil Nil Nil
3 Plant and Machinery EGM Notice, Management
certificate,CA Certificate*
102.00 NA Nil Nil Nil
4 Land Acquisition for
Expansion in South India
EGM Notice, Management
certificate,CA Certificate*
42.00 NA Nil Nil Nil
5 General Corporate Purpose EGM Notice, Management
certificate,CA Certificate*
125.00 NA Nil Nil Nil
Total 500.00

==> picture [37 x 21] intentionally omitted <==

4

* Chartered Accountant certificate from M/s. P G Bhagwat LLP dated January 24, 2026

(ii) Progress in the objects –

Sr
.
N
o
Item
Head
Source of information /
certifications considered by
Monitoring Agency for
preparation of report
Amount as
proposed
in the
Offer
Document
in Rs.
Crore
Total
unutilise
d amount
in Rs.
crore
Comments of the Monitoring
Agency
Comments of the
Board of Directors
Comments of the
Board of Directors
Amount utilised in Rs. Crore
As at
beginnin
g of the
quarter
in Rs.
Crore
During
the
quarter
in Rs.
Crore
At the
end of
the
quarter
in Rs.
Crore
Reasons
for idle
funds
Proposed
course of
action
1 Phase 2 Factory/Phase II
Building Construction-at
Chakan,Pune
EGM Notice, Management
certificate, Bank Statement
FDR Statement,CA Certificate*
187.00 0.00 0.00 0.00 187.00 Nil Nil Nil
2 Office Administration,
R&D Building – at
Chakan Pune
EGM Notice, Management
certificate, Bank Statement
FDR Statement,CA Certificate*
44.00 0.00 0.00 0.00 44.00 Nil Nil Nil
3 Plant and Machinery EGM Notice, Management
certificate, Bank Statement
FDR Statement, CA Certificate*,
Sample Invoices
102.00 0.00 60.29 60.29 41.71 KSTIL has procured plant and
machinery of Rs.60.29 crore
from its China based parent
company,KSTCL,inQ3FY26.
Nil Nil
4 Land Acquisition for
Expansion in South India
EGM Notice, Management
certificate, Bank Statement
FDR Statement,CA Certificate*
42.00 0.00 0.00 0.00 42.00 Nil Nil Nil
5 General Corporate
Purpose
EGM Notice, Management
certificate, Bank Statement
FDR Statement, CA Certificate*,
Sample Invoices
125.00 0.00 54.86 54.86 70.14 KSTIL utilized Rs.54.86 crore
towards vendor payments,
consulting fees for allotment
of securities(issue
expenses)and bank charges
during Q3FY26.
Nil Nil
Total 500.00 0.00 115.15 115.15 384.85

* Chartered Accountant certificate from M/s. P G Bhagwat LLP dated January 24, 2026

==> picture [36 x 21] intentionally omitted <==

5

(iii) Deployment of unutilized proceeds:

Sr. No. Type of instrument and name of the
entity invested in
Amount invested
(Rs. Crore)
Maturity date Earning
(Accrued Interest)
Return on
Investment (%)
Market Value as at the
end of quarter*
1 Fixed deposit – ICBC 70.00 16-02-2026 1.01 5.65% 71.01
2 Fixed deposit – ICBC 40.00 20-04-2026 0.60 5.85% 40.60
3 Fixed deposit – ICBC 110.00 06-07-2026 1.68 6.00% 111.68
4 Fixed deposit – ICBC 135.00 06-10-2026 2.06 6.05% 137.06
5 Savings & Current Account
(Preferential Issue Account)– ICBC
31.11 - - - 31.11
Less: Interest earned on FDs matured
duringthequarter
-1.25 - - - -1.25
Total 384.85 5.34 390.20

*Market Value for FDs include the accrued interest on the same as on December 31, 2025.; ICBC: Industrial and Commercial Bank of China Limited

(iv) Delay in implementation of the object(s) –

Completion Date Completion Date Delay (no. of
Comments of the Board of Directors

Comments of the Board of Directors
Objects As per the offer days/ Reason of Proposed course of
document Actual months) delay action
Phase 2 Factory/Phase II BuildingConstruction-at Chakan,Pune June 2027 - - Nil Nil
Office Administration,R&D Building– at Chakan Pune June 2027 - - Nil Nil
Plant and Machinery June 2027 - - Nil Nil
Land Acquisition for Expansion in South India June 2027 - - Nil Nil
General Corporate Purpose June 2027 - - Nil Nil

==> picture [37 x 21] intentionally omitted <==

6

4) Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document:

Source of information / certifications
Amount
Sr. No.
Item Head^
considered by Monitoring Agency for Comments of Monitoring Agency Comments of the Board of Directors
in Rs. Crore
preparation of report
1 Vendor Payment 39.19 Management Certificate, Bank
Statement, CA Certificate*,
Sample Invoices
KSTIL utilized Rs.54.86 crore
towards vendor payments,
consulting fees for allotment of
securities (issue expenses) and
bank charges during Q3FY26.
Nil
2 Consulting Fees for
allotment of securities
15.66
3 Bank Charges 0.01
Total 54.86

^ Section from the offer document related to GCP:

“We propose to deploy the balance proceeds of the Preferential Issue aggregating up to INR 124,99,92,400 towards general corporate purposes, subject to such utilization not exceeding 25% of the consideration received for allotment of Equity Shares. The general corporate purposes for which we propose to utilize the proceeds of the Preferential Issue includes meeting day to day expenses which includes amongst other things, includes, short-term working capital requirements, meeting any expense of the Company, including meeting any shortfall in capital expenditure to be incurred, salaries and wages, administration, insurance, repairs and maintenance, payment of taxes and duties, servicing of borrowings including payment of interest, brand building and other marketing expenses, meeting expenses incurred in the ordinary course of business and towards any exigencies, and any other purpose as considered expedient and as approved periodically by our Board or a duly constituted committee thereof, subject to compliance with applicable law, including the necessary provisions of the Companies Act, 2013.”

==> picture [37 x 21] intentionally omitted <==

7

Disclaimers to MA report:

a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as “Monitoring Agency/MA” ). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever.

b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by the management /officials/ consultants of the Issuer and third-party sources like statutory auditor/internal auditor which is peer reviewed audit firm appointed by the Issuer believed by it to be accurate and reliable.

c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any financial liabilities whatsoever to the users of this Report.

d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from sources it believes to be reliable, it does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives from statutory auditors/internal auditor which is peer reviewed audit firm, lawyers, chartered engineers or other experts, and relies on in its reports.

e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. As an example, the MA may rate the issuer or any debt instruments / facilities issued or proposed to be issued by the issuer that is subject matter of this report. The MA may receive separate compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors.

==> picture [37 x 21] intentionally omitted <==

8